Literature DB >> 29695599

Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder.

Yael Hacohen1, Jacqueline Palace2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29695599     DOI: 10.1212/WNL.0000000000005619

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

Review 1.  Neuromyelitis optica spectrum disorders.

Authors:  Saif Huda; Dan Whittam; Maneesh Bhojak; Jayne Chamberlain; Carmel Noonan; Anu Jacob
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

2.  OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.

Authors:  John J Chen; Elias S Sotirchos; Amanda D Henderson; Eleni S Vasileiou; Eoin P Flanagan; M Tariq Bhatti; Sepideh Jamali; Eric R Eggenberger; Marie Dinome; Larry P Frohman; Anthony C Arnold; Laura Bonelli; Nicolas Seleme; Alvaro J Mejia-Vergara; Heather E Moss; Tanyatuth Padungkiatsagul; Hadas Stiebel-Kalish; Itay Lotan; Mark A Hellmann; Dave Hodge; Frederike Cosima Oertel; Friedemann Paul; Shiv Saidha; Peter A Calabresi; Sean J Pittock
Journal:  Mult Scler Relat Disord       Date:  2022-01-11       Impact factor: 4.339

3.  Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy.

Authors:  Itay Lotan; Richard McGowan; Michael Levy
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

4.  No strong HLA association with MOG antibody disease in the UK population.

Authors:  Melissa Grant-Peters; Giordani Rodrigues Dos Passos; Hing-Yuen Yeung; Anu Jacob; Saif Huda; Maria Isabel Leite; Calliope A Dendrou; Jacqueline Palace
Journal:  Ann Clin Transl Neurol       Date:  2021-05-15       Impact factor: 5.430

5.  Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.

Authors:  Marius Ringelstein; Ilya Ayzenberg; Gero Lindenblatt; Katinka Fischer; Anna Gahlen; Giovanni Novi; Helen Hayward-Könnecke; Sven Schippling; Paulus S Rommer; Barbara Kornek; Tobias Zrzavy; Damien Biotti; Jonathan Ciron; Bertrand Audoin; Achim Berthele; Katrin Giglhuber; Helene Zephir; Tania Kümpfel; Robert Berger; Joachim Röther; Vivien Häußler; Jan-Patrick Stellmann; Daniel Whittam; Anu Jacob; Markus Kraemer; Antoine Gueguen; Romain Deschamps; Antonios Bayas; Martin W Hümmert; Corinna Trebst; Axel Haarmann; Sven Jarius; Brigitte Wildemann; Matthias Grothe; Nadja Siebert; Klemens Ruprecht; Friedemann Paul; Nicolas Collongues; Romain Marignier; Michael Levy; Michael Karenfort; Michael Deppe; Philipp Albrecht; Kerstin Hellwig; Ralf Gold; Hans-Peter Hartung; Sven G Meuth; Ingo Kleiter; Orhan Aktas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-11-16

6.  A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies.

Authors:  Lin Zhou; Xiao Tan; Ling Wang; Xiujuan Zhao; Wei Qiu; Hui Yang
Journal:  J Ophthalmol       Date:  2022-03-22       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.